Delta 9 Cannabis Inc.
DLTNFOTCHealthcare
$0.01
$-0.00(-1.95%)
Market Cap$3039509
P/E Ratio—
52W High$0.02545
52W Low$0.0069
Delta 9 Cannabis Inc. (DLTNF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
DLTNF · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2024Report Date: May 15, 2024EPS Actual
-$0.02
Revenue
$0.01B
Est. $0.01B · -15.3%
Fiscal Period
Q2 FY2024
FY ends December
Report Date
May 15, 2024
After Market Close
▼ Miss Revenue
DLTNF reports quarterly as a OTC-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$-0.11
Rev. $0.17B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$-0.11
Rev. Est.$0.17B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q2 FY2025 | Jun 27, 2025 | — | — | — | — | — | — |
| ◌ Q2 FY2025 | May 13, 2025 | — | — | — | — | — | — |
| ◌ Q4 FY2024 | Nov 18, 2024 | — | — | — | — | — | — |
| ◌ Q3 FY2024 | Aug 26, 2024 | — | — | — | — | — | — |
| — Q2 FY2024 | May 15, 2024 | — | -$0.02 | — | $0.01B | $0.01B | -15.3% |
| — Q1 FY2024 | Mar 29, 2024 | — | -$0.02 | — | $0.01B | — | — |
| — Q4 FY2023 | Nov 15, 2023 | — | -$0.02 | — | $0.01B | $0.01B | +8.8% |
| — Q3 FY2023 | Aug 14, 2023 | — | -$0.01 | — | $0.01B | $0.01B | +7.4% |
Q2 FY2025
Jun 27, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2025
May 13, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2024
Nov 18, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2024
Aug 26, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2024
May 15, 2024
EPS Actual
-$0.02
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q1 FY2024
Mar 29, 2024
EPS Actual
-$0.02
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q4 FY2023
Nov 15, 2023
EPS Actual
-$0.02
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q3 FY2023
Aug 14, 2023
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.00 | $0.00 | $0.00 | 0 |
| Q3 FY2028 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2028 | $0.00 | $0.00 | $0.00 | 0 |
| Q1 FY2028 | $0.00 | $0.00 | $0.00 | 0 |
| Q4 FY2027 | $0.00 | $0.00 | $0.00 | 0 |
| Q3 FY2027 | $0.00 | $0.00 | $0.00 | 0 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q2 FY2024 | May 15, 2024 | — | $0.02 | $0.02 | +0.29% |
| — Q1 FY2024 | Mar 29, 2024 | — | $0.04 | $0.03 | -25.47% |
| — Q4 FY2023 | Nov 15, 2023 | — | $0.03 | $0.03 | +12.78% |
| — Q3 FY2023 | Aug 14, 2023 | — | $0.05 | $0.05 | -1.98% |
| — Q2 FY2023 | Apr 3, 2023 | — | $0.06 | $0.06 | -0.71% |
| — Q1 FY2023 | Mar 31, 2023 | — | $0.06 | $0.06 | +0.54% |
| — Q4 FY2022 | Nov 14, 2022 | — | $0.08 | $0.08 | +3.30% |
| — Q3 FY2022 | Aug 15, 2022 | — | $0.13 | $0.13 | +0.55% |
Q2 FY2024+0.29%
Report Date
May 15, 2024
EPS Beat/Miss
—
Price Before
$0.02
Price After
$0.02
Q1 FY2024-25.47%
Report Date
Mar 29, 2024
EPS Beat/Miss
—
Price Before
$0.04
Price After
$0.03
Q4 FY2023+12.78%
Report Date
Nov 15, 2023
EPS Beat/Miss
—
Price Before
$0.03
Price After
$0.03
Q3 FY2023-1.98%
Report Date
Aug 14, 2023
EPS Beat/Miss
—
Price Before
$0.05
Price After
$0.05
Q2 FY2023-0.71%
Report Date
Apr 3, 2023
EPS Beat/Miss
—
Price Before
$0.06
Price After
$0.06
Q1 FY2023+0.54%
Report Date
Mar 31, 2023
EPS Beat/Miss
—
Price Before
$0.06
Price After
$0.06
Q4 FY2022+3.30%
Report Date
Nov 14, 2022
EPS Beat/Miss
—
Price Before
$0.08
Price After
$0.08
Q3 FY2022+0.55%
Report Date
Aug 15, 2022
EPS Beat/Miss
—
Price Before
$0.13
Price After
$0.13
Beat Rate0 / 8 quarters
Largest Move-25.47% (Q1 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: DLTNF ends December
Delta 9 Cannabis Inc. (DLTNF) most recently reported earnings on May 15, 2024 for Q2 FY2024, posting EPS of $-0.02 (in line with the analyst consensus of —). The next DLTNF earnings date is expected around September 1, 2026.
Each quarter, investors track DLTNF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. DLTNF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
DLTNF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
DLTNF earnings · 4 questionsDelta 9 Cannabis Inc.'s next earnings report is expected around September 1, 2026. DLTNF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; DLTNF historically reports after market close (AMC).
DLTNF earnings datewhen is DLTNF earningsDLTNF next earnings datewhen does DLTNF report earningsDLTNF earnings calendar
▸ Source: FMP · Delta 9 Cannabis Inc. SEC filings · US GAAP · Delta 9 Cannabis Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026